End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.92 CNY | -4.39% | -4.16% | -31.11% |
Apr. 18 | Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
2023 | YiBai Pharma to Repurchase Up to 40 Million Yuan Shares | MT |
Sales 2022 | 2.74B 378M | Sales 2023 | 2.82B 390M | Capitalization | 4.51B 623M |
---|---|---|---|---|---|
Net income 2022 | -426M -58.87M | Net income 2023 | 103M 14.23M | EV / Sales 2022 | 1.78 x |
Net Debt 2022 | 495M 68.35M | Net Debt 2023 | 301M 41.56M | EV / Sales 2023 | 1.7 x |
P/E ratio 2022 |
-10.3
x | P/E ratio 2023 |
43.4
x | Employees | 5,509 |
Yield 2022 * |
-
| Yield 2023 |
1.16% | Free-Float | 68.33% |
1 day | -4.39% | ||
1 week | -4.16% | ||
Current month | -5.77% | ||
1 month | +0.77% | ||
3 months | -12.69% | ||
6 months | -34.45% | ||
Current year | -31.11% |
Managers | Title | Age | Since |
---|---|---|---|
Ya Qi Dou
CEO | Chief Executive Officer | 40 | 08-04-30 |
Xian Hong Jiang
DFI | Director of Finance/CFO | 39 | 20-03-22 |
Zhi Wei Wang
BRD | Director/Board Member | 54 | 11-02-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qi Ling Dou
FOU | Founder | 64 | 95-05-31 |
Zhi Wei Wang
BRD | Director/Board Member | 54 | 11-02-20 |
Ya Qi Dou
CEO | Chief Executive Officer | 40 | 08-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 3.92 | -4.39% | 22,460,950 |
24-05-17 | 4.1 | -0.49% | 9,007,200 |
24-05-16 | 4.12 | 0.00% | 6,196,593 |
24-05-15 | 4.12 | -1.20% | 6,696,100 |
24-05-14 | 4.17 | +1.96% | 8,945,702 |
End-of-day quote Shanghai S.E., May 19, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-31.11% | 429M | |
+34.35% | 705B | |
+30.57% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+15.09% | 238B | |
-2.94% | 210B | |
+10.68% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- 600594 Stock